Ethical criticism of He Jiankui's work has been coming in fast and furious over the past week. But now scientists are also criticizing the research itself, saying it's plagued with massive technical shortcomings. His results show that “this was all a terrible idea in basically every way,” said Erik Sontheimer, who studies CRISPR in his lab at the University of Massachusetts Medical School.
from Kaiser Health News https://ift.tt/2Uhk0zB
December 05, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: California-Run Veterans Homes ‘Shortchanged, Exploited,’ Audit Finds; N.Y. Lawmakers Pass Gun Control Measures, Including Red Flag BillMedia outlets report on news from California, New York, Maryland, Minnesota, Michigan, Wyoming, Texas, New Hampshire, Missouri, Massachusetts, Florida and Washington, D.C. from Kaiser Health News http://bit.ly/2HCTQoA … Read More
New Covered California Sign-Ups PlummetThe number of new enrollees in Covered California plans plunged by nearly a quarter this year, largely because of the elimination of the tax penalty for people without insurance, officials announced Wednesday. The decrease wa… Read More
Perspectives: Trump Makes Strides In Combating High Drug Prices, But The System Is Still BrokenRead recent commentaries about drug-cost issues. from Kaiser Health News http://bit.ly/2HE0ECv … Read More
Viewpoints: Does Endorsing Single Payer, Like Kamala Harris Does, Really Go Far Enough?; Lessons From Anesthesiologists On Stemming Opioid AbuseOpinion writers weigh in on these health care topics and more. from Kaiser Health News http://bit.ly/2ShOGma … Read More
A Third Of Drug Development Costs Comes From Clinical Trials. Can Pharma Make Them Faster And Cheaper?News outlets report on stories related to pharmaceutical pricing. from Kaiser Health News http://bit.ly/2SliRZO … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment